Trinity Partners to Discuss Key Issues Facing the Biopharmaceutical Market at 2016 PSA Conference

Trinity Partners, a global life sciences consulting firm, today announced that several of its experts are attending the Pharmaceutical Strategy Conference (PSA), being held in New York City September 28 – 30.

During the conference Leslie Sandberg Orne, Senior Partner, Trinity Partners, will be moderating a panel titled ‘The Future of Primary Care Markets,’ which will discuss strategies for biopharmaceutical companies to reclaim momentum in primary care markets such as diabetes, gastrointestinal disease, and cardiovascular disease.

“As the healthcare market continues to shift, it is more important than ever that we provide strategic guidance to our biopharmaceutical clients as they navigate the journey of launching new therapies.” said Orne. “My colleagues and I look forward to the opportunity to discuss ways to resolve some of the most challenging issues our clients face in this patient-centric market.”

Each year, the PSA conference examines the key scientific, development, commercial, and business model issues adding pressure to the biopharma industry.

For more information about Trinity Partners, please visit

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s